Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Methods × Dermatologic × 90 days × Clear all

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 9 Breast 9 Thoracic 5 Tumor-Agnostic 4 Lymphoid 4 Genitourinary 4 Other hematologic neoplasm 3 Other 3 Other solid neoplasm 2 Other neoplasm 2 Gynecologic 2 Sarcoma 1 Dermatologic 1 CNS 1

Conditions

Uveal Melanoma 1

Interventions

pembrolizumab 58 Nivolumab 56 Ipilimumab 30 Specimen Handling 25 Magnetic Resonance Spectroscopy 22 Cyclophosphamide 21 Biopsy 17 fludarabine 15 cemiplimab 15 trametinib 13 relatlimab 12 Interleukin-2 12 aldesleukin 11 CTLA-4 Antigen 10 fludarabine phosphate 8 dabrafenib 7 binimetinib 7 Radiosurgery 7 Opdualag 7 atezolizumab 6 encorafenib 5 avelumab 5 Temozolomide 5 Radiotherapy 5 Introns 5 Immunoglobulin G 5 Aminolevulinic Acid 5 cobimetinib 4 Surgical Procedures, Operative 4 Standard of Care 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06075589 2026-01-15

Psychoeducation for Uveal Melanoma

Jonsson Comprehensive Cancer Center

Phase NA Active not recruiting

Uveal Melanoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡